H. W. Verspaget - Concepedia

Author

H. W. Verspaget

Leiden University

Also Known As

H W Verspaget, H. W. VERSPAGET, H. W. Verspaget, H.W. Verspaget, H.W. Verspaget,, HW Verspaget, ST Pals

Publications

713

Citations

H-Index

Concepts

All Affiliations

Leiden University Leiden University Medical Center Maastricht University

About

H. W. Verspaget is an author at Leiden University specializing in pathology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	503
2	Gastroenterology	5	5	365
3	Cell Biology	3	3	166
4	Health Sciences	1	1	59
5	Allergy	1	1	16

H. W. Verspaget

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Arno M. Janssen, C Bosman, W. van Duijn, PubMed Esophageal CancerGastrointestinal OncologyMedicineLipid PeroxidationCopper/zinc Superoxide Dismutase	2000	186
Crohn's Disease in the Elderly Martin J. Wagtmans, H. W. Verspaget, C. B. H. W. Lamers, Journal of Clinical Gastroenterology	1998	118
Plasminogen activator profiles in neoplastic tissues of the human colon. P A de Bruin, G Griffioen, H. W. Verspaget, PubMed UrologyPerineural InvasionGastrointestinal OncologyPlasminogen ActivatorMedicine	1988	83
Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease. J. W. Arndt, A van der Sluys Veer, D. Blok, PubMed ImmunologyGastroenterologyPathologyActive DiseaseIbd Patients	1993	59
In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells J. E. De Vries, WNM Dinjens, Georges K. De Bruyne, British Journal of Cancer Tumor BiologyOncologyMedicineBiological MicroenvironmentsPathology	1995	54
307 Plasminogen activator profiles in neoplastic tissues of the human colon P.A.F. de Bruin, H. W. Verspaget, G Griffioen, Fibrinolysis and Proteolysis Human TissueColorectal CancerPathologyCell-matrix InteractionHuman Colon	1988	29
Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract. M. N. Aparicio-Pagés, H. W. Verspaget, A. S. Peña, PubMed Cancer ImmunosurveillanceGastrointestinal OncologyMedicineUpper Gastrointestinal TractImmunology	1991	27
Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis H J Vloedgraven, G Griffioen, S Ganesh, British Journal of Cancer Plasminogen ActivatorsInhibitor Type 1Familial Adenomatous PolyposisMedicinePathology	1995	22
Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance E. Wrigley, H. W. Verspaget, Gordon C. Jayson, Journal of Cancer Research and Clinical Oncology Epithelial Ovarian CancerMetallothionein ExpressionMedicinePathologyGynecology	2000	17
New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapy. R. A. van Hogezand, H. W. Verspaget PubMed ImmunologyImmune RegulationPathologyIl-10 TherapyImmunotherapy	1997	16

Page 1